Infectious Diseases Trial of a Long-Acting Malaria Drug Injection Launches in RwandaGlobal Biodefense StaffNovember 5, 2026
CBRNE Radiation Countermeasure Entolimod Clears Mouse Safety Study, Moves to Survival TestGlobal Biodefense StaffNovember 3, 2026
Medical Countermeasures UK Commits £33.2 Million to Eight Vaccine Projects Targeting Ebola, Marburg, Plague and Other Epidemic ThreatsGlobal Biodefense StaffOctober 18, 2026
Soligenix’s Innate Defense Regulator Selected for NIH Commercialization Transition Funding Contracts + Grants September 20, 2018 …
CDC to Award Contract to Emergent for 9 Million Doses of Smallpox Vaccine Medical Countermeasures August 12, 2018 …
Landmark Ebola Study Provides Deep Scan of Therapeutic Antibody Combinations Medical Countermeasures August 9, 2018 …
Collaboration Among BARDA, DTRA, USAMRIID and Spero to Advance SPR994 Antimicrobial Resistance July 16, 2018 …
Soligenix Receives European and Canadian Patents for Ricin Toxin Vaccine Medical Countermeasures July 12, 2018 …
MERS-CoV: Clinical Trial Starts for Regeneron’s Monoclonal Antibody Treatments Medical Countermeasures May 18, 2018 …
Army Developing Implantable Sustained-Release Malaria Countermeasure Contracts + Grants May 13, 2018 …
Project BioShield: HHS Purchases Anthrax Countermeasure from Elusys Therapeutics Medical Countermeasures April 23, 2018 …
Business Intelligence for Influenza Vaccine Supply Chain Analytics Contracts + Grants March 15, 2018 …
Influenza: CDC Seeks Sera Studies in Europe to Evaluate Antigenic Drift Contracts + Grants March 15, 2018 …